Regulatory compliance is often treated as a final hurdle in medical device development, but many challenges arise when regulatory requirements are discovered too late. In this video, Sophie Meredith, Project Leader in Regulated Developments in TTP's Biosensing team explains why considering compliance from the earliest stages of development helps teams avoid costly redesigns, unexpected testing requirements, and delays. By addressing three key questions early - device classification and clinical risk, relevant regulatory precedents, and concept-level hazards - teams can focus development efforts, anticipate evidence requirements, and ensure the product architecture supports safety and performance from the outset.
Discover more about regulatory compliance in MedTech
About TTP’s Biosensing team
TTP’s biosensor device development specialists focus on creating advanced wearable and implantable devices, bringing together multidisciplinary expertise to deliver bespoke solutions for the most demanding requirements.
From exploring new frontiers to advancing your next breakthrough or accelerating your route to market, we tackle complex technical challenges with scientific and engineering discipline. We identify and mitigate risks early, ensuring outcomes that are both high-impact and centred on the needs of end users. When internal capacity is limited, TTP has the resources and know-how to step in and deliver.
.avif)
